 | Merck KGaA (FRA:MRK) Given a €127.00 Price Target at Morgan Stanley
americanbankingnews.com - October 21 at 7:45 AM |
| Merck KGaA (FRA:MRK) PT Set at €135.00 by Sanford C. Bernstein
americanbankingnews.com - October 21 at 6:22 AM |
 | Merck's 15-valent pneumonia vaccine successful in two more late-stage studies
seekingalpha.com - October 20 at 7:36 AM |
| Merck's Keytruda/chemo combo shows durable, sustained benefit in long term lung cancer study
seekingalpha.com - October 16 at 6:55 PM |
| Merck KGaA (FRA:MRK) Given Consensus Recommendation of "Hold" by Brokerages
americanbankingnews.com - October 16 at 1:34 AM |
| Merck KGaA (FRA:MRK) Given a €125.00 Price Target at Barclays
americanbankingnews.com - October 13 at 6:23 AM |
 | A German drugmaker just increased its stake in this Md. biopharma — and it showed in the stock price
bizjournals.com - October 12 at 4:56 PM |
| Merck KGaA (FRA:MRK) Shares Cross Above Two Hundred Day Moving Average of $107.79
americanbankingnews.com - October 9 at 2:46 AM |
| Merck HIV combo regimen shows sustained benefit in mid-stage HIV study
seekingalpha.com - October 8 at 12:47 PM |
 | Merck Mid-stage HIV Study On Islatravir- Doravirine Shows Viral Suppression Maintained
nasdaq.com - October 8 at 12:47 PM |
|
 | New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
baystreet.ca - October 7 at 11:43 AM |
 | Merck Inc (MRK) EVP, Global Svcs & CFO Robert M Davis Sold $20.4 million of Shares
uk.finance.yahoo.com - October 6 at 10:49 PM |
| Merck Banks on Keytruda, Pipeline & Deals Amid Generic Woes
nasdaq.com - October 2 at 12:44 PM |
| Merck KGaA (FRA:MRK) Given a €139.00 Price Target by Independent Research Analysts
americanbankingnews.com - October 1 at 10:55 AM |
| Celyad-Merck Team Up to Evaluate CYAD-101 in Colorectal Cancer
nasdaq.com - September 29 at 7:30 PM |
| Merck KGaA (FRA:MRK) Given a €102.00 Price Target by Goldman Sachs Group Analysts
americanbankingnews.com - September 28 at 6:06 AM |
| DZ Bank Reaffirms Buy Rating for Merck KGaA (FRA:MRK)
americanbankingnews.com - September 28 at 6:06 AM |
| Merck Enbrel biosimilar OK'd in Canada for four new uses
seekingalpha.com - September 15 at 8:56 AM |
| Merck: Health Canada Approves BRENZYS For Four New Indications
nasdaq.com - September 15 at 8:56 AM |
 | Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
fool.com - September 14 at 12:16 AM |
| Merck: Gefapixant Significantly Reduced Cough Frequency Compared To Placebo In Two Phase 3 Trials
nasdaq.com - September 8 at 9:19 AM |
| Merck To Present New Data From Oncology Development Program At ESMO Virtual Congress
nasdaq.com - September 2 at 10:11 AM |
| Why Is Merck (MRK) Up 8.4% Since Last Earnings Report?
nasdaq.com - August 30 at 2:53 PM |
| Merck : Phase 3 Study Of KEYTRUDA - Chemotherapy On Metastatic Esophageal Cancer Meets Main Goal
nasdaq.com - August 19 at 8:20 AM |
| Merck in-licenses NASH candidate from Hanmi Pharmaceutical
seekingalpha.com - August 4 at 7:29 AM |
 | Goldman Sachs Upgrades Merck On Cancer, HIV, COVID-19 Pipeline
www.msn.com - August 3 at 1:09 PM |
 | Merck Posts Second-Quarter Earnings Beat and Lifts Guidance
www.thestreet.com - July 31 at 8:04 AM |
 | Pharma giant Merck raises 2020 outlook, saying the worst of the coronavirus impact is behind it
www.cnbc.com - July 31 at 8:04 AM |
| Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline
www.nasdaq.com - July 24 at 2:53 PM |
 | New Research for Immunotherapy Combinations with Paclitaxel Helping in Breast Cancer Fight
www.marketwatch.com - July 21 at 8:41 AM |
|
| Novocure teams up with Merck in lung cancer study
seekingalpha.com - July 15 at 9:08 AM |
| Merck: Amazing Oncology Division, Underwhelming Dividend Opportunity
seekingalpha.com - July 9 at 1:04 PM |
 | Pfizer's sBLA for Bavencio Gets FDA Nod, Daurismo Gets EU Nod
finance.yahoo.com - July 3 at 5:51 PM |
| Merck's Keytruda Wins FDA Nod for Squamous Cell Skin Cancer
www.nasdaq.com - June 25 at 1:18 PM |
| Merck teams up with Yumanity in neurodegenerative diseases
seekingalpha.com - June 24 at 12:14 PM |
 | Merck Underscores Commitment to HIV with New Data Analyses to be Presented at AIDS 2020: Virtual
www.benzinga.com - June 24 at 7:13 AM |
| MORNING BID-Counteracting forces
finance.yahoo.com - June 24 at 7:13 AM |
| Merck's Pneumococcal Vaccine Meets Goal in Two Adult Studies
www.nasdaq.com - June 23 at 3:55 PM |
| Merck: FDA Approves Second Biomarker-Based Indication For KEYTRUDA
www.nasdaq.com - June 17 at 10:23 AM |
| Merck's Steglatro Non-Inferior in Cardiovascular Outcomes Study
www.nasdaq.com - June 17 at 10:23 AM |
| FDA OKs Merck's Keytruda for second application based on biomarker
seekingalpha.com - June 16 at 5:55 PM |
| MORNING BID-About-turn
finance.yahoo.com - June 16 at 7:54 AM |
| MORNING BID-Fed up
finance.yahoo.com - June 10 at 4:32 AM |
| Merck's Keytruda flunks first-line bladder cancer study
seekingalpha.com - June 9 at 6:00 PM |
 | Merck Over Roche For 25% Gains?
www.forbes.com - June 9 at 12:59 PM |
 | FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia ...
www.businesswire.com - June 5 at 7:36 AM |
| MORNING BID-Warm glow for markets
finance.yahoo.com - June 5 at 7:36 AM |
| Merck Announces Third-Quarter 2020 Dividend
www.businesswire.com - May 26 at 1:33 PM |
| IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
www.businesswire.com - May 26 at 8:03 AM |
| Merck Jumps Into Search for Covid-19 Vaccine and Treatment
www.thestreet.com - May 26 at 8:03 AM |
